News
Novo Nordisk Shares Rise After FDA Approves Wegovy for Liver Disease ...
Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback